Carregant...
Does methotrexate cause progressive fibrotic interstitial lung disease? A systematic review
The aim is to evaluate the published evidence on whether methotrexate (MTX) use causes progressive fibrotic interstitial lung disease (fILD). This PRISMA-compliant systematic review has been registered electronically with PROSPERO 2018 ID CRD42018087838, Centre of review and dissemination at the Uni...
Guardat en:
| Publicat a: | Rheumatol Int |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer Berlin Heidelberg
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8079289/ https://ncbi.nlm.nih.gov/pubmed/33515067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00296-020-04773-4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|